Back to Show
PBS News Hour
What’s keeping biosimilar drugs from the U.S. market?
NewsHour looks at a revolutionary class of drugs called "biologics." Americans have been paying more for their benefits than patients in Europe or Asia some say, because the "generic" versions or "biosimilars" have not hit the U.S. market. Dr. Emily Senay looks into why there's a delay and when American consumers can expect discounts.
Sign up now for inspiring and thought-provoking media delivered straight to your inbox.
Support Provided By

56:45
April 28, 2025 - PBS News Hour full episode

26:45
April 27, 2025 - PBS News Weekend full episode

26:45
April 26, 2025 - PBS News Weekend full episode

57:46
April 25, 2025 - PBS News Hour full episode

57:46
April 24, 2025 - PBS News Hour full episode

57:46
April 23, 2025 - PBS News Hour full episode

56:44
April 22, 2025 - PBS News Hour full episode

56:44
April 21, 2025 - PBS News Hour full episode

26:45
April 20, 2025 - PBS News Weekend full episode

26:44
April 19, 2025 - PBS News Weekend full episode

57:46
April 18, 2025 - PBS News Hour full episode

57:46
April 17, 2025 - PBS News Hour full episode